Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

NCT07328841 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

456

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG: Full course of PD-1blockades
DRUG: Cisplatin-based induction chemotherapy
RADIATION: Standard-dose radiotherapy
RADIATION: Reduced-dose radiotherapy
DRUG: Concurrent Chemotherapy

Sponsor

Ming-Yuan Chen